WELCOME to the new ModernAesthetics.com

You can find all AestheticsWire, MATV, and Modern Aesthetics® content here!

MA push banner logos
search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Injectables

News | February 6, 2020

FDA Sets November PDUFA Date for DaxibotulinumtoxinA from Revance

FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the...

Read More
MATV News: Revance to Bring Teoxane Fillers to US; Allergan Introduces Alle; More thumbnail
Play Button

MATV News: Revance to Bring Teoxane Fillers to US; Allergan Introduces Allē More

Series: MATV News | January 17, 2020

Revance enters an exclusive distribution deal with Teoxane to bring RHA line of fillers to US Market, Allergan revamps its customer loyalty rewards program, and findings of a new study may indicate what’s driving increases in body contouring procedures. 

Watch Video

News | January 10, 2020

Revance Enters Exclusive Distribution Deal with Teoxane SA for Dermal Fillers

With the signing of a new distribution agreement, Revance Therapeutics, Inc. is now the exclusive US commercialization partner of Teoxane SA for its dermal filler products. Revance has immediate and exclusive rights to...

Read More
Aesthetics Insider: Alexandra Wilkis Wilson Talks Spotlyte and More thumbnail
Play Button

Aesthetics Insider: Alexandra Wilkis Wilson Talks Spotlyte and More

Series: Aesthetics Insider | December 17, 2019

With a focus on non-branded patient education, Allergan's Spotlyte and REGI are set to open the aesthetics market. Alexandra Wilkis Wilson discusses the impact of these and other initiatives with host Steve Dayan, MD.

Watch Video
MATV News: Revance DAXI News; CSF 2019 Highlights; MiRing Device; ISAPS Stats thumbnail
Play Button

MATV News: Revance DAXI News; CSF 2019 Highlights; miRing Device; ISAPS Stats

Series: MATV News | December 16, 2019

Revance Therapeutics long-acting neuromodulator is now one step closer to FDA approval, Dr. Joel L. Cohen hosts coverage of Cosmetic Surgery Forum, and a new medical device is catching some buzz in the medical community. Plus, a look at annual statistics from the International Society of Aesthetic Plastic Surgery. 

Watch Video

Advertisement

The Latest in Injectables

Advertisement

Advertisement

View more